Med Biogene Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 06, 2020 at 10:27 am EST
Med BioGene Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced net loss was USD 9,082 compared to USD 19,708 a year ago. For the nine months, net loss was USD 42,512 compared to USD 60,196 a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.01 a year ago.